- ►allihcp.com [PDF] JW Anderson - Expert Opin. Pharmacother., 2007 - informahealthcare.com Orlistat, in the 60-mg over-the-counter dose, was recently approved by the FDA.
This lipase inhibitor blocks absorption of ~ 25% of ingested fat and has ~ 85%
of the efficacy of the 120-mg dose for weight loss. Over 16 weeks weight ... Cited by 8 - Related articles - BL Direct - All 8 versions
JL Miller, JH Silverstein - NATURE CLINICAL PRACTICE ENDOCRINOLOGY …, 2007 - sochob.cl INTRODUCTION More than one billion people worldwide are affected by obesity.1
Between 1963 and 2004, obesity rates more than tripled among adoles- cents (from
5% to 17%), more than quadrupled among children aged 6–11 years (from 4% ... Cited by 8 - Related articles - View as HTML - BL Direct - All 7 versions
D Vega, NM Maalouf, K Sakhaee - Expert Opin. Drug Saf., 2007 - informahealthcare.com Topiramate (TPM) is a neuromodulatory agent that was initially approved as an
antiepileptic drug and is increasingly used in the treatment of a number of
neurological and metabolic disorders. Among its various pharmacological ... Cited by 5 - Related articles - BL Direct - All 7 versions
V Khanna, S Arumugam, S Roy, S Mittra, VS … - Expert Opin. Ther. Targets, 2008 - informahealthcare.com Topiramate, a marketed antiepileptic drug, has been used to treat seizures and
allied neurological problems since 1999. Recently, a series of newer findings
for the use of topiramate have cropped up, which include Type 2 diabetes ... Cited by 4 - Related articles - BL Direct - All 6 versions
J de Leon - Journal of clinical psychopharmacology, 2008 - journals.lww.com This editorial expresses a personal opinion that may not be shared by other
researchers or clinicians; that is, the Bhype[ surrounding atypical
antipsychotics and metabolic syndrome is a reflection of the current ... Cited by 5 - Related articles - BL Direct - All 4 versions
RP Shank, BE Maryanoff, BE Maryanoff - CNS Neuroscience & Therapeutics, 2008 - interscience.wiley.com Topiramate (TPM; TOPAMAX ® ) is a broad-spectrum antiepileptic drug (AED) that
is approved in many world markets for preventing or reducing the frequency of
epileptic seizures (as monotherapy or adjunctive therapy), and for the ... Cited by 2 - Related articles - All 2 versions
LM Dickerson, PJ Carek - Primary Care: Clinics in Office Practice, 2009 - Elsevier Early weight loss medications were proposed as short-term adjuncts to diet and
exercise regimens, in the hopes that they would aid in initial weight loss and
help patients reach “ideal body weight.” Unfortunately, these ... Related articles - All 17 versions
GI Uwaifo, E Arioglu - members.medscape.com Obesity is a substantial public-health crisis in the United States and in the
rest of the developed world. The prevalence is increasing rapidly in numerous
developing nations worldwide. This growing rate represents a pandemic that ... Related articles - Cached - All 4 versions
SL McElroy, AI Guerdjikova, PE Keck Jr, HG … - Antiepileptic Drugs to Treat Psychiatric Disorders, 2008 - books.google.com 284 McElroy et al. studies have repeatedly shown that obesity patients seeking
weight loss treatment have elevated rates of psychopathologic symptoms and
mental disorders, especi- ally mood, eating, and anxiety disorders (11-14). ... Related articles
TA Ketter, PW Wang - Handbook of Diagnosis and Treatment of Bipolar …, 2009 - books.google.com CHAPTER 6 Management of Acute Manic and Mixed Episodes in Bipolar Disorders
Terence A. Ketter, MD Po W. Wang, MD O ver a period of 24 years, the US Food and
Drug Admin- istration (FDA) approved the first three agents for monotherapy ... Related articles
